Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomacromolecules ; 18(2): 363-373, 2017 02 13.
Article in English | MEDLINE | ID: mdl-28026947

ABSTRACT

Kojic acid (KA) is a naturally occurring fungal metabolite that is utilized as a skin-lightener and antibrowning agent owing to its potent tyrosinase inhibition activity. While efficacious, KA's inclination to undergo pH-mediated, thermal-, and photodegradation reduces its efficacy, necessitating stabilizing vehicles. To minimize degradation, poly(carbonate-esters) and polyesters comprised of KA and natural diacids were prepared via solution polymerization methods. In vitro hydrolytic degradation analyses revealed KA release was drastically influenced by polymer backbone composition (e.g., poly(carbonate-ester) vs polyester), linker molecule (aliphatic vs heteroatom-containing), and release conditions (physiological vs skin). Tyrosinase inhibition assays demonstrated that aliphatic KA dienols, the major degradation product under skin conditions, were more potent then KA itself. All dienols were found to be less toxic than KA at all tested concentrations. Additionally, the most lipophilic dienols were statistically more effective than KA at inhibiting melanin biosynthesis in cells. These KA-based polymer systems deliver KA analogues with improved efficacy and cytocompatible profiles, making them ideal candidates for sustained topical treatments in both medical and personal care products.


Subject(s)
Biocompatible Materials/chemistry , Drug Delivery Systems , Melanins/biosynthesis , Melanoma, Experimental/drug therapy , Polymers/administration & dosage , Polymers/chemistry , Pyrones/chemistry , Animals , Cell Survival/drug effects , Melanins/antagonists & inhibitors , Mice , NIH 3T3 Cells , Polymerization , Tumor Cells, Cultured
2.
Biomacromolecules ; 15(9): 3406-11, 2014 Sep 08.
Article in English | MEDLINE | ID: mdl-25082798

ABSTRACT

The bioaccessibility of salicylic acid (SA) can be effectively modified by incorporating the pharmacological compound directly into polymers such as poly(anhydride-esters). After simulated digestion conditions, the bioaccessibility of SA was observed to be statistically different (p < 0.0001) in each sample: 55.5 ± 2.0% for free SA, 31.2 ± 2.4% the SA-diglycolic acid polymer precursor (SADG), and 21.2 ± 3.1% for SADG-P (polymer). The release rates followed a zero-order release rate that was dependent on several factors, including (1) solubilization rate, (2) macroscopic erosion of the powdered polymer, (3) hydrolytic cleavage of the anhydride bonds, and (4) subsequent hydrolysis of the polymer precursor (SADG) to SA and diglycolic acid.


Subject(s)
Amyloid , Gold/chemistry , Metal Nanoparticles/chemistry , Peptides , Polyesters , Salicylic Acid , Amyloid/chemical synthesis , Amyloid/chemistry , Biological Availability , Peptides/chemical synthesis , Peptides/chemistry , Polyesters/chemical synthesis , Polyesters/chemistry , Polyesters/pharmacology , Salicylic Acid/chemistry , Salicylic Acid/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...